Healthy Lung Programme

Healthy Lung Asia 

What is the Healthy Lung Programme?

First launched in Asia, the Healthy Lung Programme was created to raise the profile of disease with policymakers and build health-system capacity to better serve patients.

In 2017, we launched the Healthy Lung Asia programme, focused on asthma and chronic obstructive pulmonary disease (COPD) and lung cancer in nine Asian markets. Since its launch, the Healthy Lung Asia programme has created 16 partnerships, has signed 8 Memorandum of Understanding reaching 660,000 people with education, diagnosis and treatment of COPD or asthma. It has also trained 15,400 physicians and 1,100 respiratory nurses, and encouraged the creation of over 6,000 respiratory centres to provide screenings.

Healthy Lung Gulf Region

In July 2018, AstraZeneca signed a Memorandum of Understanding (MoU) with the Saudi Ministry of Health to launch the Healthy Lung program in the Kingdom of Saudi Arabia.

The aim is to enhance the management and increase public awareness of asthma and chronic obstructive pulmonary disease (COPD) to reduce the number of cases and related deaths.

Healthy Lung Mexico

In March 2018, AstraZeneca began a partnership with Mexico Public Health representatives. The partnership aims to address key roadblocks to the implementation of the National Program for Respiratory Diseases.

Respiratory diseases are a significant public health concern in Mexico, with asthma and COPD ranked as the fourth leading cause of death according to official estimates. While prevalence of asthma and COPD is estimated at 7.5% and 7.9% respectively, under-diagnosis and misdiagnosis are key challenges, particularly in primary care settings and for COPD alone, 86% of cases go undiagnosed.